OpGen’s Subsidiary Curetis Meets Milestones in Collaborative Research Project with InfectoGnostics
April 03, 2023 07:30 ET
|
OpGen, Inc.
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03, 2023 ...
North America Antimicrobial Resistance Diagnostics Market Research Report 2022-2028: Industry Developments, Competitive Landscape, Partnerships and Collaborations, & Product Launches and Expansions
March 10, 2023 07:08 ET
|
Research and Markets
Dublin, March 10, 2023 (GLOBE NEWSWIRE) -- The "North America Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals,...
Global Active Pharmaceutical Ingredient Market Report to 2027: Emerging Biosimilars Market and Highly Potent Active Pharmaceutical Ingredients Present Opportunities
February 28, 2023 12:48 ET
|
Research and Markets
Dublin, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
February 14, 2023 07:30 ET
|
Selux Diagnostics
BOSTON, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that...
Global Antimicrobial Resistance Diagnostic Market Analysis Report 2023: Strategies and Trends by Pathogen and Technology with Executive Guides and 5 Year Forecasts
January 26, 2023 06:28 ET
|
Research and Markets
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, with Executive Guides and Customization" report has been...
Global Antibiotic Resistance Market Research Report 2023: The Changing Road to New Antibiotics & Technologies with 5 Year Forecasts
January 13, 2023 05:03 ET
|
Research and Markets
Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
Global Antimicrobial Resistance Diagnostics Market Report 2023: Increasing Incidences of Hospital-Acquired Infections Drives Demand
January 05, 2023 04:23 ET
|
Research and Markets
Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) -- The "Global Antimicrobial Resistance Diagnostics Market Size, Share & Industry Trends Analysis Report By Technology, By End User (Hospitals, Diagnostic...
Global Active Pharmaceutical Ingredient Global Market Report 2022: Growing Importance of Generics Bolsters Sector
December 28, 2022 06:58 ET
|
Research and Markets
Dublin, Dec. 28, 2022 (GLOBE NEWSWIRE) -- The "Global Active Pharmaceutical Ingredient Market by Type (Innovative, Generic), Manufacturer (Captive, Merchant), Synthesis (Synthetic, Biotech), Product...
Summit Therapeutics Presents Ri-CoDIFy Trial Results for Microbiome-Sparing Ridinilazole at IDWeek 2022
October 20, 2022 17:15 ET
|
Summit Therapeutics Inc.
Ridinilazole resulted in a 53% relative risk reduction in recurrence of C. difficile infection compared to treatment with vancomycin Ridinilazole preserved the gut microbiome compared to...
Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics' Clinical Advisory Board
October 17, 2022 10:01 ET
|
Selux Diagnostics
BOSTON, Oct. 17, 2022 (GLOBE NEWSWIRE) -- Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that Dr....